Selank vs Cerebrolysin
Both Selank and Cerebrolysin are used for cognitive. Here's how their evidence, dosing, and regulatory status actually compare.
Selank
Evidence BSelank (TP-7)
A synthetic analog of tuftsin with anxiolytic and nootropic properties. Modulates GABA and serotonin systems to reduce anxiety without sedation.
View full Selank profile →Cerebrolysin
Evidence BCerebrolysin (porcine brain peptide complex)
A standardized mixture of low-molecular-weight peptides from porcine brain. Decades of stroke, dementia, and TBI trial data — modest but consistent cognitive recovery effects.
View full Cerebrolysin profile →Side-by-Side
| Attribute | Selank | Cerebrolysin |
|---|---|---|
| Evidence Grade | B | B |
| FDA Status | Not FDA-approved in US — approved in Russia as anxiolytic | Not FDA-approved in US — approved in 50+ countries for stroke, traumatic brain injury, and dementia |
| Typical Dose | 200–400 mcg intranasal, evening | Trial range: 5–30 mL daily (intravenous infusion) |
| Clinics Indexed | 72 | 41 |
| Categories | cognitive, anxiety | cognitive, neuroprotection |
Key reported benefits — Selank
- ✓Anxiety reduction
- ✓Stress resilience
- ✓Cognitive clarity
- ✓Immune modulation
Key reported benefits — Cerebrolysin
- ✓Stroke recovery support
- ✓TBI rehabilitation
- ✓Cognitive function in dementia
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.